Clinical implication: clinicians should treat vaginal symptoms in patients taking semaglutide as real and addressable , but approach causality cautiously: prioritise common diagnoses (genitourinary syndrome of menopause, infections, dermatologic vulvar disease, STIs, irritant/contact dermatitis, pelvic floor disorders), identify important confounders (notably SGLT2 inhibitors, antibiotics, hormonal therapies), manage symptoms and underlying conditions, and report suspected adverse reactions when there is a reasonable temporal relationship and alternative causes are less likely
Compounded semaglutide may harm your unborn baby
Semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain flat regardless of dose increases, with HSA/FSA eligibility for added affordability
After the BUD, the preservatives may lose their effectiveness
If you have sleep apnea, heart disease, or prediabetes, coverage is often much easier to obtain